NYSE:PEAK - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD
HEALTHPEAK PROPERTIES INC
NYSE:PEAK (3/1/2024, 8:04:00 PM)
After market: 17.1 0 (0%)17.1
+0.35 (+2.09%)
The current stock price of PEAK is 17.1 USD. In the past month the price decreased by -9.14%. In the past year, price decreased by -29.57%.
Cheap Russell 2000 stocks could steal the spotlight as larger-cap counterparts become increasingly overvalued.
Top REITs are hard to find as rates remain elevated, but these three REITs have unique upside setting them apart.
High interest rates may be a going concern despite expectations to the contrary, but these stocks for high interest rates can counter that.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips “Higher for longer” may prove true as sticky inflation indicates th...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL | WELLTOWER INC | 91.36 | 86.47B | ||
VTR | VENTAS INC | N/A | 25.25B | ||
ARE | ALEXANDRIA REAL ESTATE EQUIT | 52.48 | 16.51B | ||
DOC | HEALTHPEAK PROPERTIES INC | 57.31 | 14.03B | ||
OHI | OMEGA HEALTHCARE INVESTORS | 27.65 | 10.15B | ||
HR | HEALTHCARE REALTY TRUST INC | N/A | 5.82B | ||
CTRE | CARETRUST REIT INC | 36.6 | 4.93B | ||
AHR | AMERICAN HEALTHCARE REIT INC | N/A | 4.38B | ||
DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 3.99B | ||
SBRA | SABRA HEALTH CARE REIT INC | 40.78 | 3.96B | ||
DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 3.53B | ||
NHI | NATL HEALTH INVESTORS INC | 23.38 | 3.09B |
Healthpeak Properties, Inc. is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. The company is headquartered in Denver, Colorado and currently employs 199 full-time employees. The firm acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in a diversified portfolio of high-quality healthcare properties across three core asset classes of life science, medical office, and continuing care retirement community (CCRC) real estate. The Company’s segments include Life science, Medical office, and CCRC. The Life Science segment properties contain laboratory and office space, which is leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The firm's Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms and may also include pharmacies, hospital ancillary service space, and outpatient services.
HEALTHPEAK PROPERTIES INC
4600 South Syracuse Street, Suite 500
Denver COLORADO 80237 US
CEO: Thomas M. Herzog
Employees: 199
Company Website: https://www.healthpeak.com/
Phone: 19494070700
The current stock price of PEAK is 17.1 USD.
The exchange symbol of HEALTHPEAK PROPERTIES INC is PEAK and it is listed on the New York Stock Exchange, Inc. exchange.
PEAK stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PEAK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PEAK.
PEAK has a dividend yield of 7.02%. The yearly dividend amount is currently 1.2.
The PE ratio for PEAK is 30.54. This is based on the reported non-GAAP earnings per share of 0.56 and the current share price of 17.1 USD.
ChartMill assigns a fundamental rating of 3 / 10 to PEAK. There are concerns on the financial health of PEAK while its profitability can be described as average.
Over the last trailing twelve months PEAK reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -38.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 13.95% | ||
ROA | 1.94% | ||
ROE | 4.79% | ||
Debt/Equity | 1.08 |
ChartMill assigns a Buy % Consensus number of 78% to PEAK. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -30.18% and a revenue growth 15.38% for PEAK